Rosiglitazone reduces blood pressure in female Dahl salt-sensitive rats

Steroids

Volumn 75, Issue 11, 2010, Pages 794-799

  Sartori Valinotti, Julio C ^a,c   Venegas Pont, Marcia R ^a,c   LaMarca, Babbette B ^a,c   Romero, Damian G ^b,c   Yanes, Licy L ^a,c   Racusen, Lorraine C ^d   Jones, Allison V ^a,c   Ryan, Michael J ^a,c   Reckelhoff, Jane F ^a,c  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b Department of Biochemistry ^*  (United States)

^c UNIVERSITY OF MISSISSIPPI   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertension; Inflammation; Menopause; Ovariectomy; Oxidative stress

Indexed keywords

CHOLESTEROL; ESTRADIOL; GLUCOSE; INSULIN; ISOPROSTANE DERIVATIVE; LEPTIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRATE; NITRIC OXIDE; NITRITE; OSTEOPONTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; ESTRADIOL BLOOD LEVEL; EXCRETION; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HIGH SODIUM INTAKE; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY CORTEX; MACROPHAGE; NEPHRITIS; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; RAT; SODIUM RESTRICTION; TELEMETRY; WEIGHT GAIN;

ALBUMINURIA; ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CHEMOKINE CCL2; CHOLESTEROL; ESTRADIOL; FEEDING BEHAVIOR; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN; KIDNEY; LEPTIN; NITRATES; NITRITES; OSTEOPONTIN; OVARIECTOMY; RATS; RATS, INBRED DAHL; RNA, MESSENGER; THIAZOLIDINEDIONES;

RATTUS;

EID: 77955927047     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2009.10.010     Document Type: Article

References (28)

1. I.A. Arenas, S.J. Armstrong, Y. Xu, and S.T. Davidge Chronic tumor necrosis factor-alpha inhibition enhances NO modulation of vascular function in estrogen-deficient rats Hypertension 46 2005 76 81
2. E.R. Blasi, R. Rocha, A.E. Rudolph, E.A. Blomme, M.L. Polly, and E.G. McMahon Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats Kidney Int 63 2003 1791 1800
3. C.W. Bolten, M.A. Payne, W.G. McDonald, P.M. Blanner, R.C. Chott, and S. Ghosh Thiazolidinediones inhibit the progression of established hypertension in the Dahl salt-sensitive rat Diab Vasc Dis Res 4 2007 117 123
4. M.C. Chappell, B.M. Westwood, and L.M. Yamaleyeva Differential effects of sex steroids in young and aged female mRen2. Lewis rats: a model of estrogen and salt-sensitive hypertension Gend Med 5 Suppl. A 2008 S65 S75
5. G. Chinetti, S. Griglio, M. Antonucci, I.P. Torra, P. Delerive, and Z. Majd Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages J Biol Chem 273 1998 25573 25580
6. T. Ebrahimian, Y. He, E.L. Schiffrin, and R.M. Touyz Differential regulation of thioredoxin and NAD(P)H oxidase by angiotensin II in male and female mice J Hypertens 25 2007 1263 1271
7. S. Efrati, S. Berman, A. Chachashvili, N. Cohen, Y. Siman-Tov, and Z. Averbukh Rosiglitazone treatment attenuates renal tissue inflammation generated by urinary tract obstruction Nephrology (Carlton) 2009
8. A. Foryst-Ludwig, M. Clemenz, S. Hohmann, M. Hartge, C. Sprang, and N. Frost Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma PLoS Genet 4 2008 e1000108
9. L. Guize, B. Pannier, F. Thomas, K. Bean, B. Jego, and A. Benetos Recent advances in metabolic syndrome and cardiovascular disease Arch Cardiovasc Dis 101 2008 577 583
10. S.M. Haffner, A.S. Greenberg, W.M. Weston, H. Chen, K. Williams, and M.I. Freed Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus Circulation 106 2002 679 684
11. L.M. Harrison-Bernard, I.H. Schulman, and L. Raij Postovariectomy hypertension is linked to increased renal AT1 receptor and salt sensitivity Hypertension 42 2003 1157 1163
12. C. Hinojosa-Laborde, T. Craig, W. Zheng, H. Ji, J.R. Haywood, and K. Sandberg Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats Hypertension 44 2004 405 409
13. R. Hisaki, H. Fujita, F. Saito, and T. Kushiro Tempol attenuates the development of hypertensive renal injury in Dahl salt-sensitive rats Am J Hypertens 18 2005 707 713
14. K.E. Innes, T.K. Selfe, and A.G. Taylor Menopause, the metabolic syndrome, and mind-body therapies Menopause 15 2008 1005 1013
15. M. Komajda, P. Curtis, M. Hanefeld, H. Beck-Nielsen, S.J. Pocock, and A. Zambanini Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study) Cardiovasc Diabetol 7 2008 10
16. J.M. Malinowski, and S. Bolesta Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review Clin Ther 22 2000 1151 1168
17. D.L. Mattson, L. James, E.A. Berdan, and C.J. Meister Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat Hypertension 48 2006 149 156
18. J. Myers, and T. Morgan The effect of sodium intake on the blood pressure related to age and sex Clin Exp Hypertens A 5 1983 99 118
19. P.M. Nilsson, B. Hedblad, J. Donaldson, and G. Berglund Rosiglitazone reduces office and diastolic ambulatory blood pressure following 1-year treatment in non-diabetic subjects with insulin resistance Blood Press 16 2007 95 100
20. B. Rodriguez-Iturbe, H. Pons, Y. Quiroz, K. Gordon, J. Rincon, and M. Chavez Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure Kidney Int 59 2001 2222 2232
21. B. Rodriguez-Iturbe, Y. Quiroz, M. Nava, L. Bonet, M. Chavez, and J. Herrera-Acosta Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats Am J Physiol Renal Physiol 282 2002 F191 F201
22. R. Rossi, A. Nuzzo, G. Origliani, and M.G. Modena Metabolic syndrome affects cardiovascular risk profile and response to treatment in hypertensive postmenopausal women Hypertension 52 2008 865 872
23. J.C. Sartori-Valinotti, R. Iliescu, L.A. Fortepiani, L.L. Yanes, and J.F. Reckelhoff Sex differences in oxidative stress and the impact on blood pressure control and cardiovascular disease Clin Exp Pharmacol Physiol 34 2007 938 945
24. J.C. Sartori-Valinotti, R. Iliescu, L.L. Yanes, W. Dorsett-Martin, and J.F. Reckelhoff Sex differences in the pressor response to angiotensin II when the endogenous renin-angiotensin system is blocked Hypertension 51 2008 1170 1176
25. D.R. Talbert, C.D. Allred, Y.Y. Zaytseva, and M.W. Kilgore Transactivation of ERalpha by Rosiglitazone induces proliferation in breast cancer cells Breast Cancer Res Treat 108 2008 23 33
26. R.M. Touyz, and E.L. Schiffrin Peroxisome-proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications Vasc Pharmacol 45 2006 19 28
27. X. Wang, and M.W. Kilgore Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells Mol Cell Endocrinol 194 2002 123 133
28. L.L. Yanes, J.C. Sartori-Valinotti, R. Iliescu, D.G. Romero, L.C. Racusen, and H. Zhang Testosterone-dependent hypertension and upregulation of intrarenal angiotensinogen in Dahl salt-sensitive rats Am J Physiol Renal Physiol 296 April (4) 2009 F771-9